SCHEMBL2586845

SCHEMBL2586845

O=C(O)N1CCC2(CC1)CC(=NO)c1ccccc1O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.48
EPHX2 P34913 4/20 0.47
CYP2C9 P11712 1/20 0.47
RAD52 P43351 1/20 0.47
EPHX1 P07099 2/20 0.44
SCN5A Q14524 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
EGFR P00533 1/20 0.43
BRAF P15056 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2586840 1.00 SIGMAR1 (0.48) SIGMAR1EPHX2CYP2C9RAD52EPHX1
SCHEMBL3222598 0.84 SIGMAR1 (0.66) SIGMAR1EPHX2CYP2C9EPHX1SCN5A
SCHEMBL2588053 0.84 SIGMAR1 (0.66) SIGMAR1EPHX2CYP2C9EPHX1SCN5A
SCHEMBL619791 0.83 RAD52 (0.50) SIGMAR1EPHX2RAD52EPHX1SCN5A
SCHEMBL12180397 0.83 GPR119 (0.45) EPHX2RAD52EPHX1SCN5AHRH3
SCHEMBL617867 0.81 RAD52 (0.56) SIGMAR1EPHX2RAD52HRH3EGFR
SCHEMBL620278 0.81 RAD52 (0.56) SIGMAR1EPHX2RAD52HRH3EGFR
SCHEMBL11251401 0.81 RAD52 (0.56) SIGMAR1EPHX2RAD52HRH3EGFR
SCHEMBL11471210 0.81 RAD52 (0.56) SIGMAR1EPHX2RAD52HRH3EGFR
SCHEMBL12017851 0.80 SIGMAR1 (0.68) SIGMAR1RAD52HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595989-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2013-05-29 EP disclosed
WO-2013067248-A1 BENZOXAZINES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-10 WO disclosed
WO-2011140425-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-10 WO disclosed